images (1)

FAQ's

Answer : According to Precedence Research, the global liquid biopsy market size was reached at USD 8.1 billion in 2021 and is predicted to reach USD 26.2 billion by 2030.

Answer : The global liquid biopsy market is growing at a CAGR of 14% during the forecast period 2022 to 2030.

Answer : The rapidly growing number of deaths linked to cancer and rising burden of various types of cancer such as neck and head cancer, colorectal cancer, lungs cancer, breast cancer, and bowel cancer is poised to boost the growth of the global liquid biopsy market in the upcoming years.

Answer : The top key players operating in the liquid biopsy market are Bio-Rad Laboratories, Biocept Inc., Guardant Health, QIAGEN N.V, Illumina, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, Thermo Fisher Scientific Inc..

Answer : North America dominated the global liquid biopsy market in 2020 and will lead the market in near future.